C27H41F2N5O
Neat
489.66
Nirogacestat; 1290543-63-3; PF-3084014; PF 3084014; (S)-2-(((S)-6, 8-Difluoro-1, 2, 3, 4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide; nirogacestatum; PF 03084014; QZ62892OFJ; PF3084014; (2S)-2-[[(2S)-6, 8-difluoro-1, 2, 3, 4-tetrahydronaphthalen-2-yl]amino]-N-[1-[1-(2, 2-dimethylpropylamino)-2-methylpropan-2-yl]imidazol-4-yl]pentanamide; (2S)-2-{[(2S)-6, 8-difluoro-1, 2, 3, 4-tetrahydronaphthalen-2-yl]amino}-N-(1-{1-[(2, 2-dimethylpropyl)amino]-2-methylpropan-2-yl}-1H-imidazol-4-yl)pentanamide; (2S)-2-(((2S)-6, 8-difluoro-1, 2, 3, 4-tetrahydronaphthalen-2-yl)amino)-N-(1-(1-((2, 2-dimethylpropyl)amino)-2-methylpropan-2-yl)-1H-imidazol-4-yl)pentanamide; (2S)-2-(((2S)-6, 8-difluoro-1, 2, 3, 4-tetrahydronaphthalen-2-yl)amino)-N-(1-(1-(2 and 2-dimethylpropylamino)-2-methylpropan-2-yl)imidazol-4-yl)pentanamide; RefChem:854203; PF03084014; PF-03084014; 865773-15-5; Nirogacestat [USAN]; MFCD19980705; PF-03084014 (PF-3084014)
(2S)-2-[[(2S)-6, 8-difluoro-1, 2, 3, 4-tetrahydronaphthalen-2-yl]amino]-N-[1-[1-(2 and 2-dimethylpropylamino)-2-methylpropan-2-yl]imidazol-4-yl]pentanamide
InChI=1S/C27H41F2N5O/c1-7-8-23(32-20-10-9-18-11-19(28)12-22(29)21(18)13-20)25(35)33-24-14-34(17-31-24)27(5,6)16-30-15-26(2,3)4/h11-12,14,17,20,23,30,32H,7-10,13,15-16H2,1-6H3,(H,33,35)/t20-,23-/m0/s1